Changes in Liver and Splenic Stiffness after Direct-Acting Antiviral Therapy in Chronic Hepatitis C: A Single-Centre, Prospective, Observational Study

Figure 4

Changes in spleen stiffness measurements (SSM) stratified by an SSM value of 3.2 m/s in patients with chronic hepatitis C treated with direct acting antivirals. (a) SSM <3.2 m/s (n =81). (b) SSM ≥3.2 m/s (n =48). Bars indicate Bonferroni-corrected p-values <0.05. Abbreviations: SSM, spleen stiffness measurement; PRE, pre-treatment; EOT, end of treatment; SVR48, 48 weeks after EOT; SVR96, 96 weeks after EOT.

(a)

(b)